《泰閣於臨床重症的應用》.pptVIP

泰閣於臨床重症的應用;各種抗生素之抗菌族譜;Tigecycline Dosing;泰閣之抗菌特點;;Tigecycline In Vitro Activity against 6,792 G(-) and G(+) Clinical Isolates-Global ;G(-) in Vitro Data – Taiwan;泰閣在組織內的分布(組織濃度/血清濃度);由抗菌族譜與藥物動力學衍生出之泰閣經驗性療法臨床適應症;含MRSA之複雜性皮膚軟組織感染(CSSTI);Predominant Isolates in Abscesses at Various Body Sites;Relative Distribution of Bacteria From Superficial to Deep Infections;FDA Classification of SSTIs;A Major Surgical Site Infection is a Catastrophe!;以糖尿病足為例來探討CSSTI之微生物學;Microbes and Chronic Wounds;Definitions;Microbiology of Wounds;Microbiology of Wounds;Microbiology of Wounds;Occurrence and Antimicrobia